Home / Investors / Startups / American Gene Technologies International

American Gene Technologies International

AGT is pioneering gene therapy solutions to achieve permanent cures for human diseases, including a possible cure for HIV in clinical trials

About American Gene Technologies International

American Gene Technologies (AGT) is focused on creating long-term value for patients, society, investors and donors by developing and testing cutting-edge gene therapies to cure some of humanity’s worst diseases. AGT’s HIV cure clinical trial could not only lead to a blockbuster drug that brings relief to one of society's most elusive epidemics, but it could prove the efficiency and effectiveness of AGT’s platform technologies to cure dozens of diseases ranging from viruses to cancers.

Industries

Investors in American Gene Technologies International (4)